Skip to main content

CTOS 2025 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Nicolas Penel, MD, PhD

Professor
Centre Oscar Lambret, France

Poster(s):

(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS